Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 6 studies | 25% ± 8% | |
epithelial cell | 5 studies | 30% ± 12% | |
ciliated cell | 5 studies | 27% ± 7% | |
plasmacytoid dendritic cell | 5 studies | 22% ± 7% | |
endothelial cell | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1445.16 | 1445 / 1445 | 100% | 19.63 | 183 / 183 |
liver | 100% | 780.95 | 226 / 226 | 100% | 22.96 | 406 / 406 |
lung | 100% | 1092.96 | 578 / 578 | 100% | 27.92 | 1155 / 1155 |
ovary | 100% | 843.91 | 180 / 180 | 100% | 26.70 | 430 / 430 |
stomach | 100% | 1009.93 | 359 / 359 | 100% | 22.54 | 286 / 286 |
thymus | 100% | 1060.97 | 653 / 653 | 100% | 29.64 | 604 / 605 |
breast | 100% | 1182.43 | 459 / 459 | 100% | 36.24 | 1116 / 1118 |
intestine | 100% | 1171.07 | 966 / 966 | 100% | 24.76 | 526 / 527 |
bladder | 100% | 1341.76 | 21 / 21 | 100% | 28.81 | 503 / 504 |
uterus | 100% | 1213.22 | 170 / 170 | 100% | 31.79 | 458 / 459 |
kidney | 100% | 879.58 | 89 / 89 | 100% | 26.09 | 899 / 901 |
pancreas | 100% | 659.49 | 327 / 328 | 100% | 26.57 | 178 / 178 |
prostate | 100% | 1063.06 | 245 / 245 | 100% | 37.38 | 500 / 502 |
skin | 100% | 1092.62 | 1808 / 1809 | 99% | 23.06 | 469 / 472 |
adrenal gland | 100% | 1204.91 | 258 / 258 | 99% | 26.21 | 228 / 230 |
brain | 99% | 673.10 | 2608 / 2642 | 100% | 19.97 | 705 / 705 |
adipose | 100% | 1249.54 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1447.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.73 | 29 / 29 |
muscle | 100% | 1270.05 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 987.67 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.99 | 1 / 1 |
heart | 99% | 1515.25 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 21.95 | 78 / 80 |
peripheral blood | 32% | 274.90 | 294 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042572 | Biological process | retinol metabolic process |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005634 | Cellular component | nucleus |
GO_0016229 | Molecular function | steroid dehydrogenase activity |
GO_0102354 | Molecular function | 11-cis-retinol dehydrogenase activity |
GO_0052650 | Molecular function | all-trans-retinol dehydrogenase (NADP+) activity |
Gene name | RDH14 |
Protein name | Retinol dehydrogenase 14 (All-trans and 9-cis), isoform CRA_a (cDNA, FLJ95921, Homo sapiens retinol dehydrogenase 14 (all-trans and 9-cis)(RDH14), mRNA) Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4) |
Synonyms | PAN2 SDR7C4 UNQ529/PRO1072 hCG_1641437 |
Description | FUNCTION: Retinol dehydrogenase with a clear preference for NADP. Displays high activity towards 9-cis, 11-cis and all-trans-retinol. Shows a very weak activity towards 13-cis-retinol. Has no activity towards steroid. . |
Accessions | Q9HBH5 ENST00000381249.4 Q53RX3 |